Skip to main content
Clinical Trials/NCT03875339
NCT03875339
Completed
N/A

Communities Helping the Hearing of Infants by Reaching Parents: The CHHIRP Navigator Trial

Matthew Bush, MD2 sites in 1 country2,699 target enrollmentJanuary 13, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congenital Hearing Loss
Sponsor
Matthew Bush, MD
Enrollment
2699
Locations
2
Primary Endpoint
Number of Participants Who do Not Receive Diagnostic Audiological Testing (Aim 1)
Status
Completed
Last Updated
last year

Overview

Brief Summary

Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children.

The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.

Detailed Description

For Specific Arm 1: The investigators will (1) use a stepped-wedge trial design to deliver patient navigation (PN) sequentially in 10 state-funded Kentucky Commission for Children with Special Healthcare Needs (CCSHCN) (also referred to as the Office for Children with Special Healthcare needs or OCSHCN) clinics randomized to cross from usual care to PN in steps of 6-month intervals over the project period. Prior to initiation of PN at each clinic, the control condition will be the standard of care. The overall effectiveness of PN will be tested by comparing non-adherence rates during the PN condition to those during the standard of care condition. Simultaneously, the investigators will (2) assess preliminary implementation outcomes (i.e., acceptability, adoption, recruitment/retention, and fidelity) as well as multilevel factors influencing implementation of PN in each clinic. For Specific Arm 2: Patient navigators will not be used for all subjects at participating clinics.

Registry
clinicaltrials.gov
Start Date
January 13, 2021
End Date
September 8, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Matthew Bush, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Matthew Bush, MD

Assistant Professor

University of Kentucky

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for parent-infant dyads:
  • Infant failed a hearing screening in one or both ears before postnatal hospital discharge
  • Infant was referred for follow-up diagnostic testing at one of the 10 participating CCSHCN clinics.
  • Parent able to speak either English or another language using Cyracom phone interpreting services.

Exclusion Criteria

  • Children and parents live outside Kentucky or who will be moving out of Kentucky within the first three months of life.

Outcomes

Primary Outcomes

Number of Participants Who do Not Receive Diagnostic Audiological Testing (Aim 1)

Time Frame: 3 months. (This is the amount of time from an abnormal screen at birth to an expected follow-up at a clinic or hospital.)

This outcome is the number of participants who do not follow-up at an OCSHCN Clinic for diagnostic audiologic testing after a failed newborn hearing screening from the date of randomization to 3 months after birth.

Study Sites (2)

Loading locations...

Similar Trials